More From The Market Online
‘Significant’ new milestone for Recce in clinical testing of skin infection gel
Recce Pharmaceuticals Ltd has seen its share price rise more than 1% as it completes dosing…
- Caroline Smith
- 2 mins
- 21 January 2025 15:07 (AEDT)
The world needs Nasodine: Here’s why…
With the ongoing parade of pandemic threats, a tappable market for Firebrick Pharma's Nasodine isn’t going…
- Sonia Madigan
- 4 mins
- 21 January 2025 06:00 (AEDT)
Dimerix signs up first patient for ‘highly significant’ paediatric clinical trial
Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3
- Sean Boss
- 2 mins
- 16 January 2025 14:24 (AEDT)
Publication highlights strengths of Memphasys’ antioxidant profiling system
Memphasys Ltd has seen a positive focus on its RoXsta antioxidant profiling system, through the publication…
- Caroline Smith
- 2 mins
- 16 January 2025 10:28 (AEDT)